UBS Group
HOLX

UBS Group’s Hologic HOLX Stock Holding History

UBS Group’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-71,000
Closed -$5.07M – 9619
2023
Q4 		$5.07M Buy
+71,000
New +$4.94M ﹤0.01% 2771
2022
Q3 		– Sell
-214,000
Closed -$14.8M – 10584
2022
Q2 		$14.8M Hold
214,000
– – 0.01% 1531
2022
Q1 		$16.4M Buy
+214,000
New +$15.4M 0.01% 1582
2015
Q2 		– Sell
-50,000
Closed -$1.65M – 8644
2015
Q1 		$1.65M Sell
50,000
-1,800
-3% -$55.2K ﹤0.01% 3109
2014
Q4 		$1.39M Buy
+51,800
New +$1.34M ﹤0.01% 3280

Other funds holding HOLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UBS Group's HOLX Position: Q1 2026 in Review

UBS Group increased its Hologic (HOLX) stake by 62% in Q1 2026, buying an estimated $147M and bringing the position to 5,089,745 shares worth $385M. The position accounts for 0.06% of the portfolio, ranked #339.

UBS Group first reported a position in HOLX in Q4 2014 and has held it in 46 quarters since. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • UBS Group held 5,089,745 shares of Hologic worth $385M as of Q1 2026.
  • UBS Group bought 1,950,084 Hologic shares in Q1 2026, an estimated $147M.
  • Hologic made up 0.06% of UBS Group's portfolio in Q1 2026, its #339 holding.
  • UBS Group first reported a position in Hologic in Q4 2014 and has held it in 46 quarters since.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.